Moreover, regardless of tumor resection, the detection of KRAS ctDNA emerged as the sole independent prognostic factor, and the absence or disappearance of KRAS KRAS ctDNA within six months of treatment correlated with therapeutic responses to first-line chemotherapy. The gene discussed is KRAS; the disease is neoplasm.